The investigational therapy combines mRNA technology with immunotherapy to train the immune system to target cancer cells ...

Breakthrough for bladder cancer patients as tablet treatment rolled out on NHS - Hundreds will benefit after the first ...

Hundreds of patients are expected to benefit from the recommendation by the National Institute of Health and Care Excellence.

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary ...

The drug, recommended by NICE, works by blocking certain proteins to slow down or stop the growth of cancer cells ...

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

A new, AI-powered test can detect the molecular "fingerprints" of cancer in a patient's blood using flashes of infrared light ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...